Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Antiphospholipid syndrome
  • Publication Type:
    Journal article
  • Publication Sub Type:
  • Authors:
    Manson JJ, Isenberg DA
  • Publication date:
  • Pagination:
    1015, 1020
  • Journal:
    The International Journal of Biochemistry and Cell Biology
  • Volume:
  • Issue:
  • Print ISSN:
  • Keywords:
    abnormal, Adhesion, adhesion molecule, Adhesion molecules, aggregation, Animals, annexin, Annexin V, antibodies, Antibodies, Antiphospholipid, Antibody, Anticoagulant, Anticoagulants, antiphospholipid, Antiphospholipid Syndrome, aPL, apoptosis, Arterial, As, Aspirin, BINDING, BINDING-PROTEIN, cell, Cell Adhesion, cell adhesion molecules, development, disease, Disruption, drug therapy, DYSFUNCTION, endogenous, Endothelial, endothelial cell, Endothelium, Vascular, EXPOSURE, IM, immunology, LA, lipid, Lipid Peroxidation, LIPID-PEROXIDATION, May, membrane, miscarriage, model, MODELS, MOLECULES, novel, PATHOGENESIS, Platelet, Platelet Aggregation, process, processes, PROTEIN, Proteins, RECURRENT, Research, Review, Syndrome, therapeutic use, therapy, treatment, Up-Regulation, Venous, Warfarin
  • Notes:
    DA - 20030403 IS - 1357-2725 LA - eng PT - Journal Article PT - Review PT - Review, Tutorial RN - 0 (Annexin V) RN - 0 (Antibodies, Antiphospholipid) RN - 0 (Anticoagulants) RN - 81-81-2 (Warfarin) SB - IM
Antiphospholipid syndrome (APS) is defined as the presence of venous or arterial thromboses, and/or recurrent miscarriage, with evidence of antiphospholipid antibodies (aPL). Central to the disease, is the development of the antibodies to phospholipid molecules themselves, or to their binding proteins. The production of these antibodies may depend upon the unusual exposure of cytoplasmic molecules seen during the process of apoptosis. The exact pathogenesis of antiphospholipid syndrome remains unclear, but various putative models exist. These include the up-regulation of endothelial cell adhesion molecules, membrane disruption during lipid peroxidation, a dysfunction of endogenous anticoagulants, or abnormal platelet aggregation. The mainstay of treatment is with aspirin or warfarin, and more research is required to discover novel, and safer, therapies
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by